Vernalis | search
Click here to view Vernalis news from 60+ newspapers.
Bookmark or Share- VernalisVernalis can support programs with DEL and fragment-based technologies through to establishing full drug discovery programmes for our partners. We can provide protein production, hit identification and validation through to lead optimisation, cellular biology and DMPK.
- About us - VernalisFor more than 25 years Vernalis has been working with our collaborators to tackle some of the most challenging therapeutic targets. From protein-protein interactions to novel targets classes, we have developed a deep expertise in helping our partners overcome hurdles enabling drug discovery programs and generate both robust, reliable leads and ...
- Staff - vernalis.comFor further information about partnering with Vernalis, or to find out more about our capabilities or career opportunities.
- News & Publications - VernalisVernalis announces a drug discovery collaboration with C4X Discovery in inflammatory disease Vernalis (R&D) Limited (“Vernalis”), a wholly owned subsidiary... Read more
- Ligand Announces an Expansion of Vernalis ... - Vernalis ResearchThe new three-year research collaboration combines Vernalis’ strengths in structure and biophysics-based methods as part of the Vernalis Design Platform (VDP) with the oncology expertise at Servier to enable drug discovery related to several undisclosed proteins identified as potential therapeutic targets.
More
